Abstract:Background: The efficacy of second line therapy after first line triplet in advanced colorectal cancer has not been extensively explored. Methods: Medical records of patients (pts) with ACRC treated on prospective phase I-II study with the combination of oxaliplatin, irinotecan, capecitabine and bevacizumab were retrospectively reviewed. The following data were recorded: Demographics, response to first line chemotherapy, organs involved, type of second line chemotherapy, response to second line chemotherapy, p… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.